Customer Guest
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Login | Register
Login | Register|Forgot password?
Alivus Life Sciences Limited has informed the Exchange about Link of Recording of Earnings Callmore...
Pursuant to the Regulation 30 and 46 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulati...more...
The company reported standalone net profit of Rs 150.26 crore for the quarter ended December 31 2025 as compared to Rs 136.96 crore in the same perio...more...
Alivus Life Sciences Limited has informed the Exchange about Investor Presentationmore...
Please find enclosed herewith Investors Presentation - Q3 FY 25-26.more...
Alivus Life Sciences Limited has informed the Exchange regarding a press release dated January 22 2026 titled Press Release on Unaudited Fin...more...
Enclosed please find herewith the Press Release on Unaudited Financial Results of the Company for the Third Quarter and Nine Months ended December 31...more...
Please find enclosed herewith Unaudited Financial Results for the Third Quarter and Nine Months ended 31st December 2025.more...
Alivus Life Sciences Limited has submitted to the Exchange the financial results for the period ended December 31 2025.more...
Pursuant to Regulations 30 and 33 of the SEBI (LODR) 2015 we wish to inform you that the Board at its meeting held today approved the unaudi...more...
Alivus Life Sciences Limited has informed the Exchange regarding Allotment of 55000 Shares.more...
Enclosed please find herewith intimation with respect to allotment of Equity Shares under the Employee Stock Option Scheme 2021 .more...
As of December 2025 74.91% is owned by Indian Promoters and 25.09% by Public. Institutional holds 12.21% (Insurance Companies 0.27%) and Non-Institut...more...
Alivus Life Sciences Limited has informed the Exchange about Schedule of meetmore...
Enclosed please find herewith the details of Earnings Call slated for Thursday January 22 2026 from 6:00 p.m. to 7:00 p.m. (IST) for your information...more...
Alivus Life Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading...more...
Alivus Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/01/2026 inter alia to consider ...more...
Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Intimation of Investors/Analyst Meetingmore...
BOARD MEETINGS Company Name : Aarti Industries Date : 02-02-2026